Limitations, agreements, and source contact

Nirogacestat for Adults With Desmoid Tumor/Aggressive Fibromatosis (DT/AF) · Source last updated 2026-08-20

Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.

certain Agreement

pi Sponsor Employee

false

restriction Type

LTE60

restrictive Agreement

true

point Of Contact

email

clinical@springworkstx.com

organization

SpringWorks Therapeutics

phone

877-279-4870

title

Head of Clinical Operations

Download exact source JSON → · Snapshot ctgov-results-191f4516d4760045304b24a0

Preserved source evidence · Not medical advice